M Scartozzi Selected Research

M Scartozzi Research Topics

Disease

9	Colorectal Neoplasms (Colorectal Cancer) 11/2017 - 01/2005
8	Neoplasms (Cancer) 01/2022 - 03/2004
7	Stomach Neoplasms (Stomach Cancer) 12/2016 - 03/2004
3	Colonic Neoplasms (Colon Cancer) 01/2019 - 11/2016
3	Neoplasm Metastasis (Metastasis) 09/2018 - 07/2007
2	Breast Neoplasms (Breast Cancer) 06/2017 - 12/2016
2	Lung Neoplasms (Lung Cancer) 05/2008 - 09/2005
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2008 - 09/2005
2	Ovarian Neoplasms (Ovarian Cancer) 05/2003 - 03/2000
1	Disease Progression 10/2021
1	Adenocarcinoma 10/2021
1	Thrombocytopenia (Thrombopenia) 10/2021
1	Neutropenia 10/2021
1	Diarrhea 10/2021
1	Hepatocellular Carcinoma (Hepatoma) 01/2021
1	Liver Neoplasms (Liver Cancer) 01/2021
1	Pathologic Complete Response 06/2017
1	Ischemic Stroke 08/2015
1	Coronary Disease (Coronary Heart Disease) 08/2015
1	Prostatic Neoplasms (Prostate Cancer) 01/2015
1	Renal Cell Carcinoma (Grawitz Tumor) 03/2013
1	Hypertension (High Blood Pressure) 02/2009
1	Exanthema (Rash) 05/2008
1	Malignant Mesothelioma 07/2007
1	Mesothelioma 07/2007
1	Rectal Neoplasms (Rectal Cancer) 11/2006
1	Carcinogenesis 05/2006
1	Pancreatic Neoplasms (Pancreatic Cancer) 05/2006
1	Anemia 09/2005
1	Carcinoma (Carcinomatosis) 03/2004
1	Ovarian Epithelial Carcinoma 03/2000

Drug/Important Bio-Agent (IBA)

5	ErbB Receptors (EGF Receptor)IBA 09/2012 - 07/2007
4	Cetuximab (Erbitux)FDA Link 11/2017 - 05/2011
4	Irinotecan (Camptosar)FDA LinkGeneric 07/2012 - 01/2005
3	Bevacizumab (Avastin)FDA Link 11/2016 - 02/2009
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2013 - 05/2006
3	Fluorouracil (Carac)FDA LinkGeneric 02/2009 - 04/2004
3	Cisplatin (Platino)FDA LinkGeneric 04/2004 - 03/2000
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 10/2021
2	PlatinumIBA 10/2021 - 03/2000
2	XELOXIBA 12/2017 - 11/2016
2	Trastuzumab (Herceptin)FDA Link 06/2017 - 12/2016
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2016 - 01/2005
2	Biomarkers (Surrogate Marker)IBA 02/2009 - 07/2007
1	thymosin beta(4)IBA 01/2022
1	Insulin-Like PeptidesIBA 01/2022
1	folfirinoxIBA 10/2021
1	lenvatinibIBA 01/2021
1	AlbuminsIBA 01/2021
1	BilirubinIBA 01/2021
1	Diphosphonates (Bisphosphonates)IBA 09/2018
1	Lapatinib (GW572016)FDA Link 06/2017
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 08/2015
1	Sunitinib (Sutent)FDA Link 03/2013
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 03/2013
1	Insulin-Like Growth Factor I (IGF-1)IBA 07/2012
1	Insulin (Novolin)FDA Link 07/2012
1	Angiogenesis InhibitorsIBA 02/2012
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 02/2012
1	IntegrinsIBA 04/2011
1	Biological ProductsIBA 02/2009
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 05/2008
1	Gefitinib (Iressa)FDA Link 01/2008
1	NF-kappa B (NF-kB)IBA 01/2008
1	Indicators and Reagents (Reagents)IBA 07/2007
1	AsbestosIBA 07/2007
1	TransferasesIBA 05/2006
1	Tyrosine Kinase InhibitorsIBA 05/2006
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 05/2006
1	Matrix Metalloproteinase InhibitorsIBA 05/2006
1	Monoclonal AntibodiesIBA 05/2006
1	Drug CombinationsIBA 01/2005
1	Glutathione (Reduced Glutathione)IBA 04/2004
1	Levoleucovorin FDA Link 04/2004
1	Proteins (Proteins, Gene)FDA Link 03/2004
1	Cadherins (E-Cadherin)IBA 03/2004
1	ParaffinIBA 03/2004
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 03/2000
1	Epirubicin (Ellence)FDA LinkGeneric 03/2000
1	AnthracyclinesIBA 03/2000

Therapy/Procedure

8	Drug Therapy (Chemotherapy) 10/2021 - 05/2003
8	Therapeutics 01/2021 - 05/2006
2	Adjuvant Chemotherapy 01/2019 - 11/2016
2	Radiotherapy 11/2006 - 03/2005
1	Neoadjuvant Therapy 06/2017
1	Duration of Therapy 11/2016
1	Prostatectomy (Retropubic Prostatectomy) 01/2015
1	Gastrectomy 08/2006
1	Blood Transfusion (Blood Transfusions) 09/2005
1	Lymph Node Excision (Lymph Node Dissection) 03/2005